top of page
SetPoint Medical is pioneering bioelectronic medicine to develop a safe and cost-effective approach for treatment of chronic autoimmune diseases.
AcelRx Pharmaceuticals focuses on the development and commercialization of innovative therapies. IPO in 2011 (NASDAQ: ACRX).
Aerpio Pharmaceuticals focuses on leveraging Tie2 activation for ocular disease and vascular stabilization. IPO in 2018 (NASDAQ: ARPO).
Corventis is a pioneer in wearable, wireless technologies for cardiac disease. It was acquired by Medtronic in 2014.
Pulsar Vascular Inc developed the PulseRider minimally invasive, self-expanding nitinol implant. It was acquired by Codman Neuro in 2016.
SurgiQuest Inc. develops, manufactures and markets innovative access technologies for minimally invasive surgery. It was acquired by ConMed in 2016.
Torax Medical, Inc. develops and markets products designed to treat sphincter disorders utilizing its technology platform, Magnetic Sphincter Augmentation (MSA). It was acquired by Johnson & Johnson's Ethicon in 2017.
focuses on the development of bempedoic acid. IPO in 2013 (NASDAQ: ESPR).
Crescendo Bioscience develops diagnostic tools for rheumatologists to manage patients with autoimmune and inflammatory diseases. It was acquired by Myriad Genetics in 2014.
bottom of page